Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rac1–PAK1–p38 MAPK signaling pathway is a key intracellular cascade that transmits signals from extracellular stimuli to downstream cellular responses. Rac1, a member of the Rho family of small GTPases, activates PAK1, a serine/threonine kinase, which in turn can activate the p38 MAPK subfamily. This pathway regulates diverse processes including cell proliferation, apoptosis, inflammation, cell cycle progression, and gene expression. Upstream and downstream effectors integrate environmental and genetic cues, making the pathway central to normal cell biology and numerous diseases, especially cancer and inflammatory conditions. The individual molecules within the pathway (Rac1, PAK1, p38 MAPKs) are considered drug targets, but the pathway itself is not a single canonical target[1][2][3][4].
Inhibition of kinase activity (blocks signal transduction downstream of Rac1, PAK1, or p38[1]); Modulation of GTPase activity (for Rac1)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rac1–PAK1–p38 mitogen-activated protein kinase signaling pathway.